Structured Lipid Medical Food for Pancreatic Cancer

This trial tests a new structured lipid medical food designed to help people with pancreatic cancer absorb fat more effectively and improve their nutrition. Many individuals with pancreatic cancer struggle to absorb fat due to pancreatic issues, leading to weight loss and stomach troubles. The trial aims to determine if this new food outperforms current treatments. People with pancreatic cancer who experience weight loss and stomach issues might be suitable candidates for this study. Participants will consume the structured lipid food mixed with their meals or drinks for 8 weeks to assess its effectiveness. As an unphased trial, this study provides an opportunity to explore innovative nutritional solutions for pancreatic cancer patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Encala, a special type of medical food, helps the body absorb fat more effectively without requiring assistance from the pancreas or bile. This benefit is particularly useful for individuals with pancreatic issues that hinder fat absorption. Updates from Solace Nutrition, the company behind Encala, indicate that it also aids in the absorption of certain fat-based medications, suggesting good tolerance among most users. Although large studies have not yet provided detailed safety information, Encala is designed to safely and effectively address absorption issues.¹²³⁴⁵

Unlike the standard treatments for pancreatic cancer, which often involve chemotherapy and surgery, Encala® is a structured lipid medical food that offers a novel approach. This treatment is different because it focuses on improving nutritional status and fat absorption, which can be challenging for pancreatic cancer patients. By providing a daily dose mixed with food or drinks, Encala® aims to enhance patients' overall well-being and manage gastrointestinal symptoms, potentially improving their quality of life. Researchers are excited about Encala® because it could address nutritional deficiencies in a way that current treatments do not.

Research has shown that Encala®, a special medical food, can enhance fat absorption without requiring assistance from the pancreas or bile. This is crucial for individuals with pancreatic cancer who often face challenges in absorbing fats. Studies have found that Encala® increases the absorption of nutrients and medications that dissolve in fat, potentially helping to manage symptoms related to poor fat absorption. Tests on patients with pancreatic diseases have demonstrated that Encala® can improve nutrient absorption and possibly enhance quality of life. This trial will evaluate the feasibility, tolerance, safety, and effects of Encala® on fat absorption, gastrointestinal symptoms, and nutritional status in patients with pancreatic cancer, suggesting it could be a beneficial option for those experiencing fat absorption issues due to pancreatic problems.¹²⁶⁷⁸